Salesforce has embraced artificial intelligence as a means to boost its business, but investors should steer clear of the stock until its AI transformation yields more convincing results, according to Morgan Stanley. The investment bank downgraded the software name to equal-weight from overweight. It also lowered its price target on shares to $185 from $287, suggesting 6% upside from Monday’s close. In premarket trading, the stock was down nearly 4% in the wake of the downgrade. “CRM is actively disrupting itself to position for the agentic era, but strong Agentforce KPIs have yet to drive an inflection in organic growth as legacy portfolio drags persist,” analyst Adam Wood said Tuesday in a note to clients. “Shares likely to remain…
